Modern Diagnostic & Research Centre IPO
Modern Diagnostic & Research Centre IPO
Modern Diagnostic & Research Centre IPO, a SME IPO was listed on the exchange on January 7, 2026. The price band is set between ₹85 –90 , with a face value of ₹10 . Retail investors can apply with a minimum of 1 lot, each comprising 1,600 shares — amounting to ₹144,000 at the upper price.
Modern Diagnostic & Research Centre IPO has been successfully listed on the exchange. Track the listing performance, current stock price, and post-listing trends. This information is for education only—not investment advice.
Modern Diagnostic & Research Centre IPO SME Important Dates
Get important updates regarding Modern Diagnostic & Research Centre IPO SME tentative timeline covering IPO opening, closing, basis of allotment, refunds, demat credit, and listing dates. Dates are updated as soon as they are announced.
IPO Timeline & Key Dates
* Tentative; subject to confirmation.
Price Band & Investment Details
| Issue Size |
4,099,200 shares (aggregating up to ₹36.89 Cr) |
| Issue Price | ₹85 – ₹90 |
| Face Value | ₹10/share |
| Market Lot | 1,600 shares |
| Retail Min Investment | ₹144,000 |
| Listing At | BSE |
| Sale Type | fresh issue |
| Offer for Sale |
3,892,800 shares (aggregating up to ₹35 Cr) |
| Reserved for Market Maker | ₹1.86 Cr |
| Issue Type | book building |
Modern Diagnostic & Research Centre IPO Grey Market Premium (GMP) - Current & Historical Rates
Last updated: 1 week ago
Modern Diagnostic & Research Centre IPO Grey Market Premium (GMP) History - Track Record & Historical Data
| Date | IPO Issue Price (₹) | GMP (₹) | Est. Listing Price (₹) | Est. Profit Amount (₹) | Est. Profit % | Last Updated |
|---|---|---|---|---|---|---|
| 06 Jan 2026 Latest | ₹90 | ₹13.5 | ₹103.5 | ₹13.5 |
15%
|
3:17 PM |
| 05 Jan 2026 | ₹90 | ₹13.5 | ₹103.5 | ₹13.5 |
15%
|
3:17 PM |
| 04 Jan 2026 | ₹90 | ₹16 | ₹106 | ₹16 |
17.78%
|
3:17 PM |
| 03 Jan 2026 | ₹90 | ₹16 | ₹106 | ₹16 |
17.78%
|
12:00 PM |
| 02 Jan 2026 | ₹90 | ₹16 | ₹106 | ₹16 |
17.78%
|
12:00 PM |
| 01 Jan 2026 | ₹90 | ₹14 | ₹104 | ₹14 |
15.56%
|
12:00 PM |
| 31 Dec 2025 | ₹90 | ₹13 | ₹103 | ₹13 |
14.44%
|
12:00 PM |
| 30 Dec 2025 | ₹90 | ₹10 | ₹100 | ₹10 |
11.11%
|
12:00 PM |
Subscription (Latest Snapshot)
View Detailed SubscriptionLatest snapshot: Jan 02, 2026
| Category | Subscribed (x) | No. of Applications |
|---|---|---|
| QIB | 271.13x | 427 |
| NII | 1,467.78x | 321 |
| bNII (bids above ₹10L) | 1,780.71x | 214 |
| sNII (bids below ₹10L) | 841.91x | 107 |
| Retail Investors | 867.23x | 750 |
| Total | 826x | 1,819 |
Registrar
- Registrar
- MUFG Intime India Pvt.Ltd
- Registrar Phone
- +91-810-811-4949
- Registrar Email
- moderndiagnostic.smeipo@in.mpms.mufg.com
- Registrar Address
- C-101, 1st Floor, 247 Park, Lal Bahadur Shastri Marg, Vikhroli (West), Mumbai - 400 083, India
Modern Diagnostic & Research Centre IPO Investment Limits
IPO investment limits, also referred to as application limits or bidding limits, define the minimum and maximum number of shares, lots, and investment amount that investors can apply for in an IPO based on their category (Retail, HNI, or Institutional). These limits are calculated as per SEBI guidelines and help ensure fair distribution of shares. Retail investors typically have lower minimum and maximum limits compared to High Net Worth Individuals (HNI) and Non-Institutional Investors (NII). Understanding IPO application limits is essential for investors to determine how much they can invest, calculate the number of lots they can apply for, and plan their investment strategy accordingly. The investment limits table shows the lot size, number of shares, and total amount in rupees for each investor category.
| Category | Lots | Shares | Amount (₹) |
|---|---|---|---|
| Retail (Min) | 1 | 1,600 | ₹144,000 |
| Retail (Max) | 1 | 1,600 | ₹144,000 |
| S-HNI (Min) | 2 | 3,200 | ₹288,000 |
| S-HNI (Max) | 6 | 9,600 | ₹864,000 |
| B-HNI (Min) | 7 | 11,200 | ₹1,008,000 |
Promoter Holding
Mr. Devendra Singh Yadav, Mrs. Deepali Yadav, Mrs. Asha Yadav, and Mr. Jitendra Singh are the promoters of the company.
IPO Reservation
The IPO reservation structure, also known as share allocation breakdown, details how the total issue size is distributed among different investor categories as mandated by SEBI (Securities and Exchange Board of India) regulations. This reservation table shows the exact percentage and number of shares allocated to Qualified Institutional Buyers (QIB), Retail Individual Investors (RII), High Net Worth Individuals (HNI), Non-Institutional Investors (NII), and other reserved categories like employees and shareholders. Understanding IPO reservation percentages is crucial for investors to evaluate their probability of share allotment, as each category has different subscription levels and competition. The maximum allottees column indicates the cap on the number of investors who can receive shares in each category, helping you assess the likelihood of getting an allotment based on your investor category.
| Category | Shares Offered | Maximum Allottees |
|---|---|---|
| QIB Shares Offered | 1,944,000 (47.43%) | NA |
|
•
Anchor Investor Shares Offered
|
1,161,600 (28.34%) | NA |
|
•
QIB (Ex. Anchor) Shares Offered
|
782,400 (19.09%) | NA |
| NII (HNI) Shares Offered | 585,600 (14.28%) | NA |
|
•
bNII > ₹10L
|
390,400 (9.52%) | NA |
|
•
sNII < ₹10L
|
195,200 (4.76%) | NA |
| Retail Shares Offered | 1,363,200 (33.26%) | NA |
| Market Maker Shares Offered | 206,400 (5.03%) | NA |
| Total Shares Offered | 4,099,200 (100.00%) | — |
Modern Diagnostic & Research Centre IPO Overview
Modern Diagnostic & Research Centre Limited is a diagnostic services provider in India that operates a network of 21 centers across 8 states, including 17 laboratories and 4 diagnostic centers.
They offer comprehensive radiology and pathology services such as ultrasound, CT scan, MRI, ECG, digital X-Ray, and advanced tests including molecular diagnostics and specialized panels. The company also provides home specimen collection, online reports, and customized institutional and patient diagnostic solutions.
Key Strengths:
- Nationwide diagnostic network
- Full suite of pathology and radiology services
- Advanced technology platforms
- Focus on quality, convenience, and customer service
- Centralized IT & reporting systems
- Founded In
- 2012
- Managing Director
- Mrs. Priyanshu Yadav
- Headquarters
- Company Registered Office: Plot No H-64, 1st Floor, Block-H, Bali Nagar, Near Khetar Pal Hospital, Ramesh Nagar, West Delhi - 110015, India
- Website
- www.mdrcindia.com
- Industry
- Healthcare
Financials
| Year | Revenue (₹ Cr) | Profit After Tax (₹ Cr) | Net Worth (₹ Cr) | Assets (₹ Cr) |
|---|---|---|---|---|
| 2025 | 78.8 | — | 20.73 | 64.57 |
| 2024 | 68.67 | — | 11.76 | 49.49 |
| 2023 | 56.61 | — | 5.96 | 36.54 |
Frequently Asked Questions (FAQs)
You may also like
